Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: JF Quinnelly who wrote (521)	2/3/2000 9:05:00 PM
From: jpbrody	Read Replies (1) \| Respond to of 1025

Did anyone attend that groundhog day conference? I listened to it yesterday via vcall.com. It was quite interesting. First, Sam Wohlstadter didn't speak as scheduled, instead Jacob Wohlstadter spoke. There were two new revelations of interest: 1) Roche is launching a modular system for very high volume testing sites (like LabCorp) that includes an E170 module which incorporates IGEN's ECL technology. I believe this will eventually lead to a substantial increase in royalties (assuming Roche ever pays them). 2) Tricorder. They announced that they have built something called the "origen tricorder". This is a handheld analyzer, complete with electrode, photodiode, solenoid-magnet. It sounded like he was showing a picture, but I had audio only. The tricorder is a central part of their (new) strategy. Apparently they want to be a clearinghouse for medical testing information. He was talking about putting the information onto the internet and "thin clients". It was somewhat confusing to me, and he said there would be more information in the breakout session. Did anyone attend the breakout session? I'm really curious about what the new plan is. Jim